HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueji Zhang Selected Research

Pharmaceutical Preparations

5/2022Biomimetic multifactor stimulation method for analyzing the synergism of matrix stiffness and inorganic polyphosphates on cellular behaviors.
1/2022Luminescent Covalent Organic Frameworks for Biosensing and Bioimaging Applications.
11/2020Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
10/2020Cancer Cell Membrane Camouflaged Semi-Yolk@Spiky-Shell Nanomotor for Enhanced Cell Adhesion and Synergistic Therapy.
10/2020Functional nucleic acid-based fluorescence polarization/anisotropy biosensors for detection of biomarkers.
12/2019A 3D Printed Hanging Drop Dripper for Tumor Spheroids Analysis Without Recovery.
10/2017Free-Blockage Mesoporous Anticancer Nanoparticles Based on ROS-Responsive Wetting Behavior of Nanopores.
10/2015Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.
2/2015A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores.
1/2015Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueji Zhang Research Topics

Disease

66Neoplasms (Cancer)
07/2022 - 01/2010
8Hypoxia (Hypoxemia)
03/2022 - 02/2018
5Prostatic Neoplasms (Prostate Cancer)
02/2022 - 01/2015
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2015 - 01/2015
4Lung Neoplasms (Lung Cancer)
10/2022 - 01/2020
4Infections
01/2022 - 01/2015
4Alzheimer Disease (Alzheimer's Disease)
08/2021 - 09/2015
4Breast Neoplasms (Breast Cancer)
10/2020 - 01/2015
4Neoplasm Metastasis (Metastasis)
12/2019 - 08/2013
3Melanoma (Melanoma, Malignant)
09/2020 - 01/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 01/2015
3Carcinogenesis
01/2019 - 11/2016
2Stroke (Strokes)
12/2021 - 09/2004
2Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2018
2Wounds and Injuries (Trauma)
11/2020 - 01/2010
2Disease Progression
01/2020 - 10/2015
2Hyperthermia
12/2018 - 01/2010
2Leukemia
11/2016 - 01/2015
2Lymphoma (Lymphomas)
11/2016 - 01/2015
2Type 2 Diabetes Mellitus (MODY)
12/2015 - 10/2015
2Body Weight (Weight, Body)
10/2015 - 09/2014
2Stomach Neoplasms (Stomach Cancer)
01/2015 - 01/2015
2Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 01/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015 - 01/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 03/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2022
1Polyps
05/2022
1Glioma (Gliomas)
05/2022

Drug/Important Bio-Agent (IBA)

17Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2012
17MicroRNAs (MicroRNA)IBA
12/2022 - 01/2013
13Pharmaceutical PreparationsIBA
05/2022 - 01/2013
91-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2022 - 11/2017
8Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2014
8Biological ProductsIBA
08/2021 - 01/2010
8p38 Mitogen-Activated Protein KinasesIBA
11/2016 - 01/2015
7Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 01/2013
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 01/2013
6Aurora Kinase AIBA
11/2016 - 01/2015
6plumbaginIBA
01/2015 - 03/2014
5CopperIBA
09/2021 - 01/2018
5Glutathione (Reduced Glutathione)IBA
01/2021 - 01/2013
5DNA (Deoxyribonucleic Acid)IBA
02/2020 - 03/2019
5Therapeutic UsesIBA
01/2020 - 01/2015
5Small Interfering RNA (siRNA)IBA
10/2018 - 01/2013
5MLN 8237IBA
01/2015 - 01/2015
4Metal-Organic FrameworksIBA
07/2022 - 01/2020
4cupric sulfide (CuS)IBA
01/2022 - 01/2018
4Antineoplastic Agents (Antineoplastics)IBA
05/2015 - 08/2013
3SolutionsIBA
12/2022 - 12/2018
3Photosensitizing Agents (Photosensitizers)IBA
03/2022 - 02/2018
3Silicon Dioxide (Silica)FDA LinkGeneric
10/2020 - 12/2018
3AcidsIBA
01/2017 - 01/2015
3danusertibIBA
11/2016 - 01/2015
3Aurora KinasesIBA
11/2016 - 01/2015
3TOR Serine-Threonine KinasesIBA
01/2015 - 01/2015
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2015 - 01/2015
2Nucleic AcidsIBA
10/2022 - 01/2022
2Adenosine Triphosphate (ATP)IBA
05/2022 - 01/2021
2VanadiumIBA
03/2022 - 01/2019
2Oxygen (Dioxygen)IBA
03/2022 - 11/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 01/2020
2AntioxidantsIBA
11/2021 - 01/2019
2Amyloid (Amyloid Fibrils)IBA
08/2021 - 01/2018
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2020 - 01/2019
2GraphiteIBA
01/2020 - 11/2017
2CytokinesIBA
01/2020 - 01/2015
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2018
2Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 01/2018
2Singlet OxygenIBA
01/2019 - 11/2017
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 - 12/2018
2Liposomes (Liposome)IBA
12/2018 - 01/2015
2PolymersIBA
12/2018 - 01/2010
2CateninsIBA
01/2018 - 01/2015
2PolyethyleneimineIBA
02/2017 - 01/2013
2Dipeptidyl-Peptidase IV InhibitorsIBA
12/2015 - 10/2015
2SodiumIBA
05/2015 - 01/2013
2CaspasesIBA
01/2015 - 01/2015
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2015 - 01/2015
2NaphthoquinonesIBA
01/2015 - 01/2015
2Amino AcidsFDA Link
01/2015 - 01/2015
2SirtuinsIBA
01/2015 - 01/2015
2IsotopesIBA
01/2015 - 01/2015
2Beclin-1IBA
01/2015 - 01/2015
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2015 - 01/2015
2bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2015 - 01/2015
2bcr-abl Fusion ProteinsIBA
01/2015 - 01/2015
1HydrogelsIBA
12/2022
1Hemoglobins (Hemoglobin)IBA
10/2022
1aspartic acid glycine arginineIBA
07/2022
1PolyphosphatesIBA
05/2022
1ChlorophyllIBA
03/2022

Therapy/Procedure

26Therapeutics
07/2022 - 01/2013
10Drug Therapy (Chemotherapy)
11/2021 - 01/2013
6Photochemotherapy (Photodynamic Therapy)
03/2022 - 11/2017
6Photothermal Therapy
01/2022 - 11/2017
4Precision Medicine
11/2020 - 11/2017
4Lasers (Laser)
07/2019 - 01/2012
2Bandages (Bandage)
11/2020 - 01/2010
2Quantum Dots (Quantum Dot)
01/2019 - 11/2017